Modifying Pirfenidone Treatment For Patients With Atypical Liver Function

Patent No. EP2500019 (titled "Modifying Pirfenidone Treatment For Patients With Atypical Liver Function") was filed by Intermune on Nov 6, 2009. The application was issued on Apr 6, 2016.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ALFRED E TIEFENBACHERJan 3, 2017HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
SANDOZDec 22, 2016ELKINGTON AND FIFE
RATIOPHARMDec 15, 2016BEST

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2500019

INTERMUNE
Application Number
EP12166074A
Filing Date
Nov 6, 2009
Status
Revoked
Feb 8, 2019
Publication Date
Apr 6, 2016